We wish to express our gratitude to all our shareholders for your continuing support.

In the current period (FY ended March 2025), the final year of the medium-term management plan “SHIP VISION 2024”, we achieved increased revenue and profits, successfully handing over the baton of solid growth to the new medium-term management plan “SHIP VISION 2030”, which begins in the FY ending March 2026.

Consolidated financial results of the exceeded the continued to achieve an increase in sales and profit; net sales is 678.2 billion yen (increased 7.5% YoY), operating profit is 24.7 billion yen (increased 1.0% YoY) and profit attributable to owners of parent is 15.1 billion yen (increased 9.6% YoY).In particular, net sales significantly exceeded the original 630 billion yen, target outlined in the medium-term management plan “SHIP VISION 2024.”
Although operating income reached a record high, it fell short of our original plan due to a challenging business environment. The Group considers that securing rising trend in profits can be sufficient results despite the aggressive growth investment including capital investment for logistics hub in Medical Supply Business and upfront costs associated with the opening of the new facility in Lifecare Business based on the steady accumulation of profits including execution of several large-scale projects in Total Pack Produce Business as planned.
With regard to profits return for shareholders, dividends per share of the period was 58 yen, which exceeds that of the last period when commemorative dividend of 30th anniversary was paid, achieving our ninth consecutive annual dividend increase.
We remain committed to maintaining a stable dividend payout ratio of 30% or more　(36.2% for the current fiscal year), continuing to return profits in alignment with earnings growth.

The Group formulated five-year medium-term management plan “SHIP VISION 2030” and starts new efforts in the next period.

The medium-term management plan positions “Growth”, “Profitability” and “Capital efficiency” in quantitative targets as important management index, targeting a “five-year Compound Annual Growth Rate CAGR 5% in net sales”, “Operating profit margin 4%” and “ROE 12%.” About concrete efforts, our basic policy is to achieve “Portfolio Management through the Optimization of Group Management Resources”. This includes more aggressive internal Group reorganization and integration for enhancing promptness of management and further organize the foundation for efficient utilization of management resources. Furthermore, we optimize in the base of the Group which realizes the consolidated net sales of 1 trillion yen, which is the target in the long term, support the business contents after the realization of the target from every aspect including organization/human resource, investment/finance and governance. We promote policies including “Creating new business”, “Reorganization and integration” and “Expansion of the field of growth” with emphasis for constructing new business portfolio based on the above. In particular, for new business creation, we will broaden the scope of our solutions under “Creating environment for medical professionals.” while actively advancing initiatives in the growing “Well-Being” field to foster environments where people can live better lives. We sincerely appreciate your continued support and encouragement.